Cipla receives final USFDA nod for Lanreotide injection to treat tumours

by IANS |

Mumbai, May 22 (IANS) Drugmaker Cipla on Wednesday announced that the US Food and Drug Administration (USFDA) has granted it final approval for the Lanreotide injection, used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs).


Acromegaly is a hormonal disorder, while GEP-NETs is a rare type of tumour that can form in the pancreas or other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix.


The company said it has received final approval for Lanreotide injection in doses 120 mg/0.5 mL, 90 mg/0.3 mL, and 60 mg/0.2 mL.


It added that the USFDA approval is based on an Abbreviated New Drug Application (NDA).


Cipla's Lanreotide Injection is an AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) injection.


Lanreotide injection is supplied as 120 mg/0.5 mL, 90 mg/0.3 mL, and 60 mg/0.2 mL single-dose, pre-filled, and ready-to-inject syringe.


According to IQVIA (IMS Health), Somatuline Depot (Lanreotide) had US sales of approximately $898 million in the last year, that is till March 2024.

Latest News
Aero India 2025: IAF, Army chiefs take sortie in Tejas together Sun, Feb 09, 2025, 04:19 PM
Champions Trophy: Bosch named replacement for Nortje in South Africa's squad Sun, Feb 09, 2025, 04:11 PM
Namibia's founding President Sam Nujoma dies at 95 Sun, Feb 09, 2025, 04:06 PM
Tears of joy as five Thai hostages return home after a year in Hamas captivity Sun, Feb 09, 2025, 03:48 PM
ED, Economic intelligence bureau launch probe into CSR fund scam in Kerala Sun, Feb 09, 2025, 03:43 PM
WPL 2025: All-rounder Deepti Sharma to lead UP Warriorz Sun, Feb 09, 2025, 02:54 PM
Piyush Goyal slams states seeking Central funds on basis of tax contribution Sun, Feb 09, 2025, 01:55 PM
2nd ODI: Kohli returns, Varun handed ODI debut as England elect to bat against India Sun, Feb 09, 2025, 01:42 PM
Watchdog to expand English corporate disclosure info for foreign investors Sun, Feb 09, 2025, 01:15 PM
Market Outlook: Delhi polls' outcome, Q3 earnings, inflation data set to drive D-Street action Sun, Feb 09, 2025, 01:13 PM
3 killed, 10 injured as truck carrying pilgrims to Maha Kumbh collides with SUV in MP Sun, Feb 09, 2025, 01:08 PM
12 Maoists killed in encounter in Chhattisgarh's Bijapur Sun, Feb 09, 2025, 12:59 PM
UAE condemns Netanyahu's remarks on Palestinian state in Saudi Arabia Sun, Feb 09, 2025, 12:55 PM
KL Rahul left surprised by huge crowd at Barabati Stadium for India's practice session Sun, Feb 09, 2025, 12:53 PM
23 Indian startups raise over $138 million in funding this week Sun, Feb 09, 2025, 12:45 PM